Performance in FY2020
In a challenging operating scenario, we have delivered on our commitments with strong financials, driven by a rich innovation spectrum in our product portfolio and growing prominence in bio-solutions.
` 35,756 cr
EBITDA* 18 %^
` 7,452 cr
Profit after tax* 38%^
` 2,801 cr
Earnings per share** 19%^
` 773 cr
` 4,400 cr
Significant potential of combined pipeline (peak sales value)
` 20,000 cr
We continue to push the edge of our ‘sustainability envelope’ by closely monitoring and improving upon our environmental performance through faster adoption of green energy; and lowering our emission levels significantly.
Power emanates from renewable sources in our largest two manufacturing plants
Of our plants achieved zero liquid discharge
We broad-based our societal impact by supporting communities in the vicinity of our operations and gradually expanding our arc of need-based interventions.
Of net profit spend on CSR activities
Lives impacted through CSR interventions
*Considers Arysta numbers for full year FY2019 and before adjustment for purchase price allocation
**Considers Arysta numbers for two months for FY2019 (acquisition in Feb 2019) and after adjustment for purchase price allocation
# Percentage based on CSR spent in India as a percentage of UPL Limited standalone profits